Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients
Effect of Oral Supplementation With the Amino Acid L-arginine on Peri- Operative Cardio-vascular Risk in Non-selected Patients - Role of Pre-operative Determination of Plasma ADMA Levels for Therapeutic Stratification.
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Listed as NCT01413815, this NA trial focuses on Cardiovascular Complication and remains completed. Sponsored by Universitätsklinikum Hamburg-Eppendorf, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Sep 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitätsklinikum Hamburg-Eppendorf
For direct contact, visit the study record on ClinicalTrials.gov .